Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 16/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24863509 | 0.92 | KLKB1 (0.38) | KLKB1PTGDR2 | |
| SCHEMBL24863510 | 0.90 | KLKB1 (0.38) | KLKB1PTGDR2 | |
| SCHEMBL25659783 | 0.89 | KLKB1 (0.52) | KLKB1 | |
| SCHEMBL25659967 | 0.85 | KLKB1 (0.42) | KLKB1MEN1KMT2A | |
| SCHEMBL24863503 | 0.84 | KLKB1 (0.64) | KLKB1 | |
| SCHEMBL25660016 | 0.83 | KLKB1 (0.41) | KLKB1PTGDR2 | |
| SCHEMBL24863526 | 0.83 | KLKB1 (0.64) | KLKB1 | |
| SCHEMBL24863505 | 0.82 | KLKB1 (0.43) | KLKB1 | |
| SCHEMBL24863398 | 0.82 | KLKB1 (0.52) | KLKB1 | |
| SCHEMBL25659921 | 0.82 | KLKB1 (0.42) | KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167098-A1 | HETEROCYCLIC COMPOUND | MEDSHINE DISCOVERY INC. (CN) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167098-A1 | HETEROCYCLIC COMPOUND | CYP11B2, CYP4F11, CYP11B1 | KLKB1 1724/4885MEN1 511/4885KMT2A 4628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.